144 related articles for article (PubMed ID: 29407591)
21. (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.
TenBrink RE; Bergh CL; Duncan JN; Harris DW; Huff RM; Lahti RA; Lawson CF; Lutzke BS; Martin IJ; Rees SA; Schlachter SK; Sih JC; Smith MW
J Med Chem; 1996 Jun; 39(13):2435-7. PubMed ID: 8691438
[No Abstract] [Full Text] [Related]
22. N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT(7) receptor selectivity versus multireceptor profile.
Canale V; Kurczab R; Partyka A; Satała G; Słoczyńska K; Kos T; Jastrzębska-Więsek M; Siwek A; Pękala E; Bojarski AJ; Wesołowska A; Popik P; Zajdel P
Bioorg Med Chem; 2016 Jan; 24(2):130-9. PubMed ID: 26706111
[TBL] [Abstract][Full Text] [Related]
23. 6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics.
Favor DA; Powers JJ; White AD; Fitzgerald LW; Groppi V; Serpa KA
Bioorg Med Chem Lett; 2010 Oct; 20(19):5666-9. PubMed ID: 20801650
[TBL] [Abstract][Full Text] [Related]
24. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
Liégeois JF; Deville M; Dilly S; Lamy C; Mangin F; Résimont M; Tarazi FI
J Med Chem; 2012 Feb; 55(4):1572-82. PubMed ID: 22268448
[TBL] [Abstract][Full Text] [Related]
25. Discovery of aryl-piperidine derivatives as potential antipsychotic agents using molecular hybridization strategy.
Zhu C; Li X; Zhao B; Peng W; Li W; Fu W
Eur J Med Chem; 2020 May; 193():112214. PubMed ID: 32182489
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a new class of multi-target heterocycle piperidine derivatives as potential antipsychotics with pro-cognitive effect.
Gao L; Hao C; Chen J; Ma R; Zheng L; Wu Q; Liu X; Liu BF; Zhang G; Chen Y; Jin J
Bioorg Med Chem Lett; 2021 May; 40():127909. PubMed ID: 33705900
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics.
Cao X; Zhang Y; Chen Y; Qiu Y; Yu M; Xu X; Liu X; Liu BF; Zhang L; Zhang G
J Med Chem; 2018 Nov; 61(22):10017-10039. PubMed ID: 30383372
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of a series of piperidine-2,6-dione-piperazine (piperidine) derivatives as multireceptor atypical antipsychotics.
Chen Y; Xu X; Liu X; Liu BF; Zhang G
Arch Pharm (Weinheim); 2012 Nov; 345(11):859-69. PubMed ID: 22886598
[TBL] [Abstract][Full Text] [Related]
29. Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.
Heusler P; Newman-Tancredi A; Loock T; Cussac D
Eur J Pharmacol; 2008 Feb; 581(1-2):37-46. PubMed ID: 18190908
[TBL] [Abstract][Full Text] [Related]
30. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
[TBL] [Abstract][Full Text] [Related]
31. Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
Czopek A; Kołaczkowski M; Bucki A; Byrtus H; Pawłowski M; Kazek G; Bojarski AJ; Piaskowska A; Kalinowska-Tłuścik J; Partyka A; Wesołowska A
Bioorg Med Chem; 2015 Jul; 23(13):3436-47. PubMed ID: 25936259
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis and Biological Investigation of Flavone Derivatives as Potential Multi-Receptor Atypical Antipsychotics.
Gao L; Yang Z; Xiong J; Hao C; Ma R; Liu X; Liu BF; Jin J; Zhang G; Chen Y
Molecules; 2020 Sep; 25(18):. PubMed ID: 32911828
[TBL] [Abstract][Full Text] [Related]
33. Continuation of structure-activity relationship study of novel benzamide derivatives as potential antipsychotics.
Xu M; Guo S; Yang F; Wang Y; Wu C; Jiang X; Zhao Q; Chen W; Tian G; Zhu F; Xie Y; Hu T; Wang Z; He Y; Shen J
Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800306. PubMed ID: 30702760
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia.
Langlois X; Megens A; Lavreysen H; Atack J; Cik M; te Riele P; Peeters L; Wouters R; Vermeire J; Hendrickx H; Macdonald G; De Bruyn M
J Pharmacol Exp Ther; 2012 Jul; 342(1):91-105. PubMed ID: 22490380
[TBL] [Abstract][Full Text] [Related]
35. Chemical puzzles in the search for new, flexible derivatives of lurasidone as antipsychotic drugs.
Zaręba P; Drabczyk AK; Jaśkowska J; Satała G
Bioorg Med Chem; 2020 May; 28(10):115459. PubMed ID: 32247749
[TBL] [Abstract][Full Text] [Related]
36. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics.
Chen Y; Wang S; Xu X; Liu X; Yu M; Zhao S; Liu S; Qiu Y; Zhang T; Liu BF; Zhang G
J Med Chem; 2013 Jun; 56(11):4671-90. PubMed ID: 23675993
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
Ishibashi T; Horisawa T; Tokuda K; Ishiyama T; Ogasa M; Tagashira R; Matsumoto K; Nishikawa H; Ueda Y; Toma S; Oki H; Tanno N; Saji I; Ito A; Ohno Y; Nakamura M
J Pharmacol Exp Ther; 2010 Jul; 334(1):171-81. PubMed ID: 20404009
[TBL] [Abstract][Full Text] [Related]
40. Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties.
Canale V; Kurczab R; Partyka A; Satała G; Lenda T; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Zajdel P
Eur J Med Chem; 2016 Jan; 108():334-346. PubMed ID: 26698537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
